Literature DB >> 16643491

Metabolic abnormalities associated with calyceal diverticular stones.

Brian K Auge1, Michaella E Maloney, Barbara J Mathias, Paul K Pietrow, Glenn M Preminger.   

Abstract

OBJECTIVE: To review the metabolic analyses of patients with calyceal diverticular stones who had surgical treatment of their calculi and to examine the effect of selective medical therapy on stone recurrence, as recent reports suggest that metabolic abnormalities contribute to stone development. PATIENTS AND METHODS: In all, 37 patients who had endoscopic treatment of symptomatic calyceal diverticular calculi were retrospectively reviewed. Stone composition and initial 24-h urine collections (24-h urinary volumes, pH, calcium, sodium, uric acid, oxalate, citrate, and the number of abnormalities/patient per collection) were compared with 20 randomly selected stone-forming patients (controls) with no known anatomical abnormalities. Stone formation rates before and after the start of medical therapy were calculated in the patients available for follow-up.
RESULTS: Twelve of the diverticulum patients (five men and seven women) had complete 24-h urine collections, all of whom had at least one metabolic abnormality. Seven patients had hypercalciuria, four had hyperuricosuria and three had mild hyperoxaluria. The most common abnormality was a low urine volume; 11 of the 12 patients had urine volumes of <2000 mL/day (range 350-1950). Ten patients had hypocitraturia in at least one of the two 24-h urine samples; seven had low urinary citrate levels (172-553 mg/day) on both samples. The findings were similar in the control group. The diverticulum patients had 3.1 abnormalities/patient, and the controls had 2.9 abnormalities/patient (P > 0.05). No patients had gouty diathesis and none developed cystine stones. Stone analyses were similar in the two groups; both developed either calcium oxalate or mixed calcium oxalate/calcium phosphate stones. Six patients were followed for a mean of 23.1 months while on selective medical therapy; only one passed any additional stones, thought to be existing calculi, for a remission rate of five of six (83%).
CONCLUSIONS: All patients with symptomatic calyceal diverticular stones who had comprehensive metabolic evaluation had metabolic abnormalities. There were similar abnormalities in the control random stone-formers. The abnormalities were corrected with selective medical therapy, as shown by the high remission rate. We recommend that, for patients with symptomatic calyceal diverticular calculi, a metabolic evaluation should be considered to determine stone forming risk factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643491     DOI: 10.1111/j.1464-410X.2006.06134.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

1.  The pathogenesis of calyceal diverticular calculi.

Authors:  Brian R Matlaga; Nicole L Miller; Colin Terry; Samuel C Kim; Ramsay L Kuo; Fredric L Coe; Andrew P Evan; James E Lingeman
Journal:  Urol Res       Date:  2007-02-02

Review 2.  Stones in special situations.

Authors:  Mordechai Duvdevani; Stavros Sfoungaristos; Karim Bensalah; Benoit Peyronnet; Amy Krambeck; Sanjay Khadji; Ahmet Muslumanuglu; David Leavitt; Jude Divers; Zeph Okeke; Arthur Smith; Janelle Fox; Michael Ost; Andreas J Gross; Hassan Razvi
Journal:  World J Urol       Date:  2017-03-07       Impact factor: 4.226

Review 3.  Calyceal diverticula: a comprehensive review.

Authors:  Nikhil Waingankar; Samih Hayek; Arthur D Smith; Zeph Okeke
Journal:  Rev Urol       Date:  2014

4.  Caliceal diverticulum in pediatric patients: the spectrum of imaging findings.

Authors:  Boaz Karmazyn; Martin Kaefer; S Gregory Jennings; Ranjini Nirmala; Molly E Raske
Journal:  Pediatr Radiol       Date:  2011-05-07

Review 5.  The imaging appearances of calyceal diverticula complicated by uroliathasis.

Authors:  H Stunell; G McNeill; R F J Browne; R Grainger; W C Torreggiani
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

6.  The treatment option for calyceal diverticulum stones: flexible ureteroscopy lithotripsy (FURL) or all-seeing needle-assisted percutaneous nephrolithotomy (PCNL)?

Authors:  Jin Zeng; Lu Zhang; Xingfa Chen; Hui He; Xiang Li
Journal:  Urolithiasis       Date:  2022-08-22       Impact factor: 2.861

7.  Percutaneous management of caliceal diverticuli.

Authors:  Amy E Krambeck; James E Lingeman
Journal:  J Endourol       Date:  2009-10       Impact factor: 2.942

8.  Management of calyceal diverticular calculi: a comparison of percutaneous nephrolithotomy and flexible ureterorenoscopy.

Authors:  Okan Bas; Ekrem Ozyuvali; Yasin Aydogmus; Nevzat Can Sener; Onur Dede; Serhat Ozgun; Fatih Hizli; Cagri Senocak; Omer Faruk Bozkurt; Halil Basar; Abdurrahim Imamoglu
Journal:  Urolithiasis       Date:  2014-09-24       Impact factor: 3.436

9.  Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran.

Authors:  Mohammad Mehdi Hosseini; Ahad Eshraghian; Ilnaz Dehghanian; Dariush Irani; Mitra Amini
Journal:  Int Urol Nephrol       Date:  2009-06-23       Impact factor: 2.370

10.  Percutaneous holmium laser fulguration of calyceal diverticula.

Authors:  Amjad Alwaal; Raed A Azhar; Sero Andonian
Journal:  Case Rep Urol       Date:  2012-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.